338
Views
10
CrossRef citations to date
0
Altmetric
Endocrinology

Current utilization patterns for long-acting insulin analogues including biosimilars among selected Asian countries and the implications for the future

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, , , , ORCID Icon, , ORCID Icon, , , , ORCID Icon, , & ORCID Icon show all
Pages 1529-1545 | Received 15 Mar 2021, Accepted 17 Jun 2021, Published online: 14 Jul 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Che Suraya Zin, Norny Syafinaz Ab Rahman, Nor Ilyani Mohamed Nazar, Amanj Kurdi & Brian Godman. (2023) Trends in the Cost of Medicines, Consultation Fees and Clinic Visits in Malaysia’s Private Primary Healthcare System: Employer Health Insurance Coverage. Journal of Multidisciplinary Healthcare 16, pages 1683-1697.
Read now

Articles from other publishers (9)

Domenico Cucinotta, Annalisa Giandalia & Giuseppina Russo. (2023) After 100 years of life, is there an insulin crisis? The problem of insulin costs and the opportunity of biosimilar insulins. AboutOpen 11:1, pages 4-7.
Crossref
Thomas DanneLutz HeinemannThomas R. Pieber. (2023) New Insulins, Biosimilars, and Insulin Therapy. Diabetes Technology & Therapeutics 25:S1, pages S-44-S-69.
Crossref
Wanqin Hu, Chunxia Zhai, Hongyu Sun, XingYu Gong, Liangyu Cui, Lin Cai, Qiqun Zong, Guanghui Yu, Fang Wang & Yanfeng Zou. (2023) The global burden of disease attributable to metabolic risks in 204 countries and territories from 1990 to 2019. Diabetes Research and Clinical Practice 196, pages 110260.
Crossref
Eunice Twumwaa Tagoe, Justice Nonvignon, Robert van Der Meer, Itamar Megiddo & Brian Godman. (2022) Challenges to the delivery of clinical diabetes services in Ghana created by the COVID-19 pandemic. Journal of Health Services Research & Policy 28:1, pages 58-65.
Crossref
Paulo H.R.F. Almeida, Brian Godman, Vania dos Santos Nunes-Nogueira, Lívia L.P. de Lemos, Francisco de Assis Acúrcio, Augusto A. Guerra-Junior, Vânia E. de Araújo, Alessandra M. Almeida & Juliana Alvares-Teodoro. (2022) A Cross-Sectional Study of Quality of Life Among Brazilian Adults With Type 1 Diabetes Treated With Insulin Glargine: Findings and Implications. Clinical Diabetes 40:3, pages 312-326.
Crossref
Yazed AlRuthia, Ohud H. Bahari, Suliman Alghnam, Ali M. Alrumaih, Hassan Asiri, Mohammed Alshammari, Mansour Alhowimel & Hana A. Al-Abdulkarim. (2022) Real-World Impact of Switching From Insulin Glargine (Lantus®) to Basaglar® and Potential Cost Saving in a Large Public Healthcare System in Saudi Arabia. Frontiers in Public Health 10.
Crossref
Ileana Mardare, Stephen M. Campbell, Johanna C. Meyer, Israel Abebrese Sefah, Amos Massele & Brian Godman. (2022) Enhancing Choices Regarding the Administration of Insulin Among Patients With Diabetes Requiring Insulin Across Countries and Implications for Future Care. Frontiers in Pharmacology 12.
Crossref
A. F. Verbovoy, Yu. A. Dolgikh & L. A. Sharonova. (2022) Insulin biosimilars in clinical practice. Meditsinskiy sovet = Medical Council:21-1, pages 131-138.
Crossref
Brian Godman, Magdalene Wladysiuk, Stuart McTaggart, Amanj Kurdi, Eleonora Allocati, Mihajlo Jakovljevic, Francis Kalemeera, Iris Hoxha, Anna Nachtnebel, Robert Sauermann, Manfred Hinteregger, Vanda Marković-Peković, Biljana Tubic, Guenka Petrova, Konstantin Tachkov, Juraj Slabý, Radka Nejezchlebova, Iva Selke Krulichová, Ott Laius, Gisbert Selke, Irene Langner, András Harsanyi, András Inotai, Arianit Jakupi, Svens Henkuzens, Kristina Garuolienė, Jolanta Gulbinovič, Patricia Vella Bonanno, Jakub Rutkowski, Skule Ingeberg, Øyvind Melien, Ileana Mardare, Jurij Fürst, Sean MacBride-Stewart, Carol Holmes, Caridad Pontes, Corinne Zara, Marta Turu Pedrola, Mikael Hoffmann, Vasileios Kourafalos, Alice Pisana, Rita Banzi, Stephen Campbell & Bjorn Wettermark. (2021) Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and Implications. BioMed Research International 2021, pages 1-16.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.